Loading…
CSL is a global biotechnology company that develops and delivers biotherapies for rare and serious diseases, vaccines, and treatments for iron deficiency and nephrology. Its portfolio includes CSL Behring, CSL Seqirus, and CSL Vifor, addressing conditions such as bleeding disorders, immunodeficiencies, hereditary angioedema, and kidney disease.
AI named Csl from November 2025 to January 2026.